What You Should Know:
- The traditional approach to fostering biopharma growth is no longer sustainable, according to Accenture research and analysis. The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021.
- The analysis reveals multiple factors are eroding the sustainability of an inorganic growth strategy, such as rising costs of M&A,
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America
What You Should Know:
- Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin America.
- The acquisition demonstrates progress toward building diverse representation in clinical research and is a strategic first step following Reify Health’s $220 million investment
Read More
Merck Digital Sciences Studio Launches to Support Biomedical Startups
What You Should Know:
- Merck, today announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development.
- MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck.
MDSS Accelerator Program Focus
The MDSS is a collaboration between
Read More
Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions
Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) over the past 20 years coupled with progressive legislation have been a catalyst for an explosion in safety data over this period.
Since the World Health Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented
Read More
Medidata Launches New Clinical Operations Technologies
What You Should Know:
- Today, Medidata, a Dassault Systèmes company, is announcing technology enhancements that address key issues in clinical trial management and oversight.
- These enhancements are to Medidata Detect and Rave CTMS (Clinical Trial Management System), which will improve both data oversight and reporting for sponsors and contract research organizations (CROs) in two meaningful ways: how they comprehensively monitor their trial data, and how they
Read More
Walgreens Launches New Clinical Trial Business to Address Access & Diversity
What You Should Know:
- Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.
- Walgreens flexible clinical trial model combines the company’s vast foundation of patient insights, partner-enabled health and technology capabilities and in-person and virtual care options to break through barriers to engaging broader and more diverse communities.
Patient Recruitment
Read More
BrightInsight Launches Digital Disease Management Solution for Biopharma
What You Should Know:
- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions launches its Disease Management Solution.
- This configurable suite of digital applications includes a Patient App, Analytics Dashboards and Healthcare Provider Interfaces. The Disease Management Solution, built on the compliant BrightInsight® Platform on Google Cloud, meets biopharma and medtech customers’ core needs out-of-the-box to support
Read More
L7 Informatics Raises $38M to Digitalize Precision Healthcare
What You Should Know:
- L7 Informatics, a leader in software for life sciences that delivers a flexible end-to-end platform for precision healthcare, today announced a $38M investment led by Banneker Partners with participation from its pre-existing investors.
- The company will use the new funding to accelerate product development, expand L7|ESP's global reach, and build on L7's outstanding customer support.
Precision healthcare offers significant improvements in
Read More
PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth
What You Should Know:
- A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns.
- Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year
Read More
C2i Genomics, Karkinos Healthcare Partner to Bring AI-Powered Cancer R&D to India
What You Should Know:
- C2i Genomics, a cancer intelligence company, announced a strategic partnership with Karkinos Healthcare to develop the first whole-genome sequencing (WGS) MRD test that will further R&D efforts in India.
- This partnership will improve diagnostic labs in India by providing them with the ability to validate and monitor the quality of whole-genome cancer screening and minimal residual disease (MRD) products faster.
AI-Powered Cancer Detection and Monitoring
Read More
